Randomized phase III trial evaluating motivational interviewing and text interventions to optimize adherence to breast cancer endocrine therapy (Alliance A191901): the GETSET protocol

Randomized phase III trial evaluating motivational interviewing and text interventions to optimize adherence to breast cancer endocrine therapy (Alliance A191901): the GETSET protocol

Abstract Background Hormone receptor-positive (HR +) breast cancer is the most common type of breast cancer in the USA but has excellent long-term outcomes in recent decades, in part due to effective oral endocrine therapy (ET). ET medications are typically prescribed for 5 to 10 years, depending on...

Full description

Bibliographic Details
Main Authors: Joannie Ivory, Stephanie B. Wheeler, Sarah Drier, Heather Gunn, David Zahrieh, Electra Paskett, Michelle Naughton, Rachel Wills, Kayla Swetel, Selina Chow, Katherine Reeder-Hayes
Format: Article
Language:English
Published: BMC 2023-10-01
Series:Trials
Subjects:
Breast cancer
Endocrine therapy
Adherence
Clinical trials
Diversity
Health services research
Online Access:https://doi.org/10.1186/s13063-023-07672-8

Internet

https://doi.org/10.1186/s13063-023-07672-8

Similar Items